Redox homeostasis and inflammation in fibroblasts of patients with Friedreich Ataxia: a possible cross talk. [PDF]
Quatrana A +5 more
europepmc +1 more source
Friedreich ataxia: what can we learn from non-GAA repeat mutations? [PDF]
Lynch DR, Shen M, Wilson RB.
europepmc +1 more source
Gait characteristics in people with Friedreich ataxia: daily life versus clinic measures. [PDF]
Casey HL +10 more
europepmc +1 more source
Managing Aminotransferase Elevations in Patients with Friedreich Ataxia Treated with Omaveloxolone: A Review and Expert Opinion on Use Considerations. [PDF]
Perlman S +4 more
europepmc +1 more source
Uniparental IsoDisomy: a case study on a new mechanism of Friedreich ataxia. [PDF]
Sperelakis-Beedham B +12 more
europepmc +1 more source
New and Emerging Drug and Gene Therapies for Friedreich Ataxia. [PDF]
Scott V, Delatycki MB, Tai G, Corben LA.
europepmc +1 more source
Inhibition of Rho-Associated Kinases ROCK1 and ROCK2 as a Therapeutic Strategy to Reactivate the Repressed <i>FXN</i> Gene in Friedreich Ataxia. [PDF]
Fang M +8 more
europepmc +1 more source
Related searches:
Idebenone in Friedreich's ataxia
Expert Opinion on Pharmacotherapy, 2008Friedreich's ataxia is an autosomal recessive neurodegenerative disease where impaired mitochondrial function and excessive production of free radicals play a central pathogenetic role. Idebenone, a synthetic analogue of coenzyme Q, is a powerful antioxidant that was first administrated to Friedreich's ataxia patients less than 10 years ago.The aim of ...
Caterina Tonon, Raffaele Lodi
exaly +3 more sources
To the Editor .—In the recent article entitled "Auditory Function in Friedreich's Ataxia: Electrophysiologic Study of a Family" in theArchives(1981;107:254-256), Shanon and co-workers reported electrophysiologic abnormalities in a family suffering from Friedreich's ataxia.
S, Satya-Murti, A T, Cacace
openaire +2 more sources

